Aptevo Therapeutics closes $2.1 million direct offering and …

The filing relating to the common stock shares issued in the registered direct offering has been previously submitted to the Securities and Exchange Commission. This filing pertains to the number of shares issued and the details of the offering.

The filing covers the specifics of the shares that were issued as part of the direct offering. It outlines the number of shares issued, the price at which they were offered, and any additional details related to the offering. This information is crucial for investors and regulatory authorities to understand the terms of the offering and ensure transparency in the market.

By filing this information with the SEC, the company is adhering to regulatory requirements and providing important information to investors. This filing helps to maintain the integrity of the financial markets by ensuring that all relevant details are disclosed to the public.

Investors rely on these filings to make informed decisions about their investments. By providing details about the common stock offering, the company is giving investors the information they need to evaluate the offering and determine whether it aligns with their investment goals.

This filing is a standard practice for companies that issue common stock through direct offerings. It allows the company to document the terms of the offering and provide a clear overview of the shares issued.

Overall, this filing relating to the common stock shares issued in the direct offering is an essential document for investors, regulatory authorities, and the company itself. It ensures transparency and provides critical information about the offering to all stakeholders.